Evidence map›Paper›PMID 38601452›Full record

ArticleTranslational lung cancer research2024

Regulatory role of the miR-142-3p/

Jing Meng, Zongchang Song, Shuxian Cong, Qiong Sun, Qinyun Ma, Weiwei Shi, Linxuan Wang

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational lung cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jing Meng *Department of Oncology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Zongchang Song *Department of Oncology, Shanghai University Affiliated Mengchao Cancer Hospital, Shanghai, China.
Shuxian Cong *Department of Thoracic Surgery, PKUCare Zibo Hospital, Zibo, China.
Qiong SunDepartment of Oncology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Qinyun MaDepartment of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Weiwei ShiDepartment of Oncology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Linxuan WangDepartment of Pulmonary and Critical Care Medicine, Shanghai Pudong New Area People's Hospital, Shanghai, China.
Chinese PLA General Hospital · CNFudan University · CNPudong New Area People's Hospital · CNShanghai Cancer Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With its diverse genetic foundation and heterogeneous nature, non-small cell lung cancer (NSCLC) needs a better comprehension of prognostic evaluation and efficient treatment targeting. Methods: Bioinformatics analysis was performed of The Cancer Genome Atlas (TCGA)-NSCLC and GSE68571 dataset. Overlapping differentially expressed genes (DEGs) were used for functional enrichment analysis and constructing the protein-protein interaction (PPI) network. In addition, key prognostic genes were identified through prognostic risk models, and their expression levels were verified. The phenotypic effects of cell division cycle 25C ( Results: Conclusions: MiR-142-3p emerged as a key player in governing autophagy and apoptosis by directly targeting

Indexed as

autophagycell division cycle 25C (CDC25C)MiR-142-3pnon-small cell lung cancer (NSCLC)

Identifiers

PMID38601452
PMCPMC11002511
OpenAlexW4393237279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.